Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Action on Metabolism Depending on Genetic Heterogeneity - a Randomized, Placebo-controlled Double Blind Study

NCT03525002 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03525002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Action on Metabolism Depending on Genetic Heterogeneity - a Randomized, Placebo-controlled Double Blind Study
Lead sponsor
University Hospital Tuebingen
Phase
Phase 2
Overall status
Completed
Start date
May 3, 2018
Completion date
August 14, 2024
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

obesity